
Search Clinical Trials
Sponsor Condition of Interest |
---|
Systemic Biomarkers of Brain Injury From Hyperammonemia
Children's National Research Institute
Urea Cycle Disorder
Organic Acidemia
Maple Syrup Urine Disease
Glutaric Acidemia I
Fatty Acid Oxidation Disorder
Ammonia is a waste product of protein and amino acid catabolism and is also a potent
neurotoxin. High blood ammonia levels on the brain can manifest as cytotoxic brain edema
and vascular compromise leading to intellectual and developmental disabilities. The
following aims are proposed:
Aim 1 of th1 expand
Ammonia is a waste product of protein and amino acid catabolism and is also a potent neurotoxin. High blood ammonia levels on the brain can manifest as cytotoxic brain edema and vascular compromise leading to intellectual and developmental disabilities. The following aims are proposed: Aim 1 of this study will be to determine the chronology of biomarkers of brain injury in response to a hyperammonemic (HA) brain insult in patients with an inherited hyperammonemic disorder. Aim 2 will be to determine if S100B, NSE, and UCHL1 are altered in patients with two other inborn errors of metabolism, Maple Syrup Urine Disease (MSUD) and Glutaric Acidemia (GA1). Type: Observational Start Date: Jul 2020 |
Augmented Reality For MRI-Guided Interventions
Children's National Research Institute
Infections
Pain
Diagnosis
Image Guided Needle Biopsy
The purpose of this study is to determine feasibility and safety of using an augmented
reality system in patients undergoing MRI-Guided needle procedures. expand
The purpose of this study is to determine feasibility and safety of using an augmented reality system in patients undergoing MRI-Guided needle procedures. Type: Interventional Start Date: Feb 2024 |
Development of a City-Wide Cohort of HIV-Infected Persons in Care in the District of Columbia: the1
George Washington University
HIV
AIDS
The goal of the DC Cohort is to establish a clinic-based city-wide longitudinal cohort
that will describe clinical outcomes, and improve the quality of care for outpatients
with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) in
Washington, DC. expand
The goal of the DC Cohort is to establish a clinic-based city-wide longitudinal cohort that will describe clinical outcomes, and improve the quality of care for outpatients with Human Immunodeficiency Virus/Acquired Immune Deficiency Syndrome (HIV/AIDS) in Washington, DC. Type: Observational Start Date: Jan 2011 |
A Study to See if Tolvaptan Can Delay Dialysis in Infants and Children Who at Enrollment Are 28 Day1
Otsuka Pharmaceutical Development & Commercialization, Inc.
Autosomal Recessive Polycystic Kidney Disease (ARPKD)
The primary objective of this study is to evaluate the effect of tolvaptan on the need
for renal replacement therapy in pediatric subjects with autosomal recessive polycystic
kidney disease (ARPKD) expand
The primary objective of this study is to evaluate the effect of tolvaptan on the need for renal replacement therapy in pediatric subjects with autosomal recessive polycystic kidney disease (ARPKD) Type: Interventional Start Date: Jul 2022 |
- Previous
- Next